<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">712</id>
  <title>T3D0711</title>
  <common-name>Sodium dichromate</common-name>
  <description>Sodium dichromate is a chemical compound of sodium and hexavalent chromium. It is produced during the processing of chromium ore and may be used in organic synthesis. Hexavalent chromium refers to chemical compounds that contain the element chromium in the +6 oxidation state. Chromium(VI) is more toxic than other oxidation states of the chromium atom because of its greater ability to enter cells and higher redox potential. (L16, L529)</description>
  <cas>10588-01-9</cas>
  <pubchem-id>25408</pubchem-id>
  <chemical-formula>Cr2H14Na2O7</chemical-formula>
  <weight>261.824970</weight>
  <appearance>Orange crystals.</appearance>
  <melting-point></melting-point>
  <boiling-point></boiling-point>
  <density></density>
  <solubility></solubility>
  <specific-gravity></specific-gravity>
  <flash-point></flash-point>
  <vapour-pressure></vapour-pressure>
  <route-of-exposure>Inhalation  (L16) ; oral (L16) ; dermal (L16)</route-of-exposure>
  <target></target>
  <mechanism-of-toxicity>Hexavalent chromium's carcinogenic effects are caused by its metabolites, pentavalent and trivalent chromium. The DNA damage may be caused by hydroxyl radicals produced during reoxidation of pentavalent chromium by hydrogen peroxide molecules present in the cell. Trivalent chromium may also form complexes with peptides, proteins, and DNA, resulting in DNA-protein crosslinks, DNA strand breaks, DNA-DNA interstrand crosslinks, chromium-DNA adducts, chromosomal aberrations and alterations in cellular signaling pathways. It has been shown to induce carcinogenesis by overstimulating cellular regulatory pathways and increasing peroxide levels by activating certain mitogen-activated protein kinases. It can also cause transcriptional repression by cross-linking histone deacetylase 1-DNA methyltransferase 1 complexes to CYP1A1 promoter chromatin, inhibiting histone modification. Chromium may increase its own toxicity by modifying metal regulatory transcription factor 1, causing the inhibition of zinc-induced metallothionein transcription. (A12, L16, A34, A35, A36)</mechanism-of-toxicity>
  <metabolism>Chromium is absorbed from oral, inhalation, or dermal exposure and distributes to nearly all tissues, with the highest concentrations found in kidney and liver. Bone is also a major storage site and may contribute to long-term retention. Hexavalent chromium's similarity to sulfate and chromate allow it to be transported into cells via sulfate transport mechanisms. Inside the cell, hexavalent chromium is reduced first to pentavalent chromium, then to trivalent chromium by many substances including ascorbate, glutathione, and nicotinamide adenine dinucleotide. Chromium is almost entirely excreted with the urine. (A12, L16)</metabolism>
  <toxicity>LD50: 51.10 mg/kg (Oral, Rat) (L16)
LD50: 1000 mg/kg (Dermal, Rabbit) (L16)
LC50: 124.42 mg/m3 over 4 hours (Inhalation, Rat) (L16)</toxicity>
  <lethaldose>1 to 3 grams for an adult human (hexavalent chromium). (A119)</lethaldose>
  <carcinogenicity>1, carcinogenic to humans. (L135)</carcinogenicity>
  <use-source>Sodium dichromate is produced during the processing of chromium ore and may be used in organic synthesis. (L529)</use-source>
  <min-risk-level>Intermediate Oral: 0.005 mg/kg/day (L134) 
Chronic Oral: 0.001 mg/kg/day (L134)</min-risk-level>
  <health-effects>Hexavalent chromium is a known carcinogen. Chronic inhalation especially has been linked to lung cancer. Hexavalent chromium has also been know to cause reproductive and developmental defects. (A12)</health-effects>
  <symptoms>Breathing hexavalent chromium can cause irritation to the lining of the nose, nose ulcers, runny nose, and breathing problems, such as asthma, cough, shortness of breath, or wheezing. Ingestion of hexavalent chromium causes irritation and ulcers in the stomach and small intestine, as well as anemia. Skin contact can cause skin ulcers. (L16)</symptoms>
  <treatment>There is no know antidote for chromium poisoning. Exposure is usually handled with symptomatic treatment. (L16) </treatment>
  <created-at type="dateTime">2009-03-26T21:21:31Z</created-at>
  <updated-at type="dateTime">2026-04-05T20:36:05Z</updated-at>
  <interacting-proteins>Sulfate transporter (P50443) Sulfate anion transporter 1 (Q9H2B4) (A12)</interacting-proteins>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id></kegg-compound-id>
  <omim-id></omim-id>
  <chebi-id>39483</chebi-id>
  <biocyc-id></biocyc-id>
  <ctd-id>C016104</ctd-id>
  <stitch-id>Sodium dichromate</stitch-id>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id>455</actor-id>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins>Sulfate transporter (P50443) 
Sulfate anion transporter 1 (Q9H2B4) 
(A12)</transporting-proteins>
  <moldb-smiles>O.O.O.O.O.O.O.[Na].[Na].[Cr].[Cr]</moldb-smiles>
  <moldb-formula>Cr2H14Na2O7</moldb-formula>
  <moldb-inchi>InChI=1S/2Cr.2Na.7H2O/h;;;;7*1H2</moldb-inchi>
  <moldb-inchikey>DOQKPLCDSRESLL-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal">276.077</moldb-average-mass>
  <moldb-mono-mass type="decimal">275.934503</moldb-mono-mass>
  <origin>Exogenous</origin>
  <state>Solid</state>
  <logp nil="true"/>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id>21539159</chemspider-id>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference></synthesis-reference>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM000638</chemdb-id>
  <dsstox-id>DTXSID8021274</dsstox-id>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id>NS00085738</susdat-id>
  <iupac>dichromium heptahydrate disodium</iupac>
</compound>
